Kawasaki syndrome, more commonly called Kawasaki disease, is a childhood illness that causes inflammation in the walls of blood vessels throughout the body, with a particular tendency to damage the coronary arteries that supply the heart. It primarily strikes children under age 5 and affects boys more often than girls. In the continental United States, roughly 9 to 20 out of every 100,000 children under 5 develop the disease each year.
The condition is treatable, but timing matters. Up to 25% of children who go untreated develop coronary artery aneurysms, which are dangerous bulges in weakened artery walls. With prompt treatment, that number drops to about 5%.
What Causes It
No one has identified a single definitive cause. The current scientific consensus is that Kawasaki disease results from an exaggerated immune response to some environmental or infectious trigger in children who are genetically susceptible. Something, likely entering through the respiratory tract, sets off a chain reaction: the immune system activates aggressively, flooding the body with inflammatory signals that attack the walls of medium-sized arteries.
For decades, researchers assumed the trigger was a conventional infection because of the disease’s seasonal patterns and the fact that children often have cold-like symptoms beforehand. More recent work has shifted that thinking. Some evidence points toward a fungal toxin or other airborne environmental agent originating from northeastern China, with global wind patterns potentially influencing where and when outbreaks cluster. Infections may play a role in priming the immune system rather than directly causing the disease. Animal studies have successfully triggered a Kawasaki-like syndrome using certain fungal species, lending weight to this theory.
The Three Phases of Illness
Kawasaki disease unfolds in three recognizable stages. The acute phase lasts roughly one to two weeks and is when the fever and most visible symptoms appear. Inflammation of the coronary arteries typically begins 6 to 8 days into the illness, making early diagnosis critical. The subacute phase follows, lasting from about week two through week four. The fever usually resolves during this period, but this is actually when the risk of coronary aneurysm formation is highest and when the characteristic peeling of skin on the fingers and toes appears. Finally, the convalescent phase extends from about week four until blood markers return to normal, which can take six to eight weeks.
Recognizing the Symptoms
Diagnosis is based on a pattern of physical signs rather than a single lab test. The hallmark is a persistent high fever lasting five or more days (though diagnosis can be made at four days if other signs are strongly present) along with at least four of the following five features:
- Red eyes: both eyes become bloodshot without discharge or crusting, which helps distinguish it from pink eye.
- Mouth and lip changes: bright red, cracked lips, a “strawberry tongue” with a bumpy red surface, and redness throughout the mouth and throat.
- Rash: a widespread rash that can take several forms, appearing flat, raised, or hive-like, but never blister-like.
- Hand and foot changes: redness and swelling of the palms and soles during the acute phase, followed by peeling skin around the fingernails and toenails in weeks two and three.
- Swollen lymph node: a firm, tender lump on one side of the neck, typically at least 1.5 centimeters across.
Not every child checks all the boxes. Some develop what’s called incomplete Kawasaki disease, where fewer than four of the classic signs appear. This is a genuine diagnostic challenge because the risk of heart damage is just as real. In these cases, doctors use a combination of blood tests and heart ultrasound to look for signs of inflammation and early coronary artery changes that support the diagnosis.
Conditions That Look Similar
Several other childhood illnesses share features with Kawasaki disease, which can delay diagnosis. Scarlet fever produces a similar rash and strawberry tongue. Viral infections can cause fever, rash, and red eyes in various combinations. Since the pandemic, multisystem inflammatory syndrome in children (MIS-C) has been a particularly important condition to distinguish from Kawasaki disease. MIS-C is linked to SARS-CoV-2 infection and tends to affect older children and adolescents rather than toddlers. It also causes more severe heart muscle dysfunction and shock but is less likely to produce coronary aneurysms. Inflammatory markers in the blood tend to be much higher in MIS-C than in Kawasaki disease.
How It Damages the Heart
The immune system’s inflammatory response doesn’t just cause the visible symptoms. Internally, white blood cells invade the walls of blood vessels and begin breaking them down. The coronary arteries are the primary target, particularly the left anterior descending artery and the right coronary artery, two of the most important vessels supplying the heart muscle.
As inflammation destroys the elastic tissue inside the artery wall, it creates weak spots. Blood pressure pushing against these weakened areas can cause them to balloon outward, forming aneurysms. Small aneurysms often resolve on their own over time. Larger ones, called giant aneurysms, can persist for years or permanently, creating ongoing risks including blood clots and, in rare cases, heart attacks even in young adults. The disease also causes inflammation of the heart muscle itself during the acute phase, though this typically resolves with treatment.
Treatment and What to Expect
The standard treatment is a single high-dose infusion of immunoglobulin, a concentrated solution of antibodies delivered intravenously, ideally within the first 10 days of illness and preferably within the first 7. This treatment dramatically reduces the risk of coronary aneurysms from 25% down to about 5%. It works by broadly calming the immune system’s overreaction, though the exact mechanism isn’t fully understood.
Aspirin is also part of the standard approach. At higher doses during the acute phase, it helps reduce inflammation. At lower doses continued after the fever resolves, it prevents blood clots from forming in any damaged coronary arteries by blocking platelets from sticking together. This is one of the rare situations where aspirin is used in children.
Most children respond well to the first round of treatment. The fever typically breaks within 24 to 48 hours of the immunoglobulin infusion. A small percentage of children don’t respond and need a second dose or alternative therapies.
Long-Term Follow-Up
Even after the acute illness resolves, children who’ve had Kawasaki disease need heart monitoring. How much and for how long depends on whether any coronary artery damage occurred. Children with no evidence of artery changes generally have follow-up heart ultrasounds at 6 months, 12 months, and again at 5 years, with some centers adding an assessment around age 14. For most of these children, the long-term outlook is excellent.
Children who developed coronary aneurysms need closer surveillance. Small aneurysms that return to normal size are monitored yearly. Medium or giant aneurysms, even after they’ve improved, require ultrasounds every 6 to 12 months, sometimes indefinitely. Giant aneurysms that persist require imaging every 3 to 6 months along with ongoing treatment to prevent clotting.
The broader concern is that even coronary arteries that appear to have healed may not be entirely normal at a microscopic level. Some researchers have raised the question of whether adults who had Kawasaki disease as children carry a modestly elevated cardiovascular risk later in life, which is one reason follow-up extends into adolescence and sometimes beyond.